Press Releases

Yourgene Health and Genetix Launch First Local Non-invasive Prenatal Testing Service in Colombia

CovarsaDx Expands Collaborative Efforts Through MDIC Membership and Key Initiatives

CovarsaDx, a prominent Clinical Research Organization (CRO) renowned for its expertise in vitro diagnostics (IVDs) and medical devices, is proud to announce its membership in the Medical Device Innovation Consortium (MDIC). This partnership marks a significant milestone in CovarsaDx’s ongoing mission to advance innovation in healthcare technology by providing reliable clinical validation results from an elite network of experienced investigators.

Duke Street Bio Granted Approval by European Medicines Agency to Launch Next-Generation PARP1-Selective Inhibitor Trial

Duke Street Bio Ltd has announced that the European Medicines Agency (EMA) has granted approval to commence a clinical trial for its highly-selective PARP1 inhibitor, DSB2455.

DevCo has completed a strategic capital raise for its long-term investment in Medix Biochemica

Medix Biochemica has announced DevCo has completed a capital raise resulting in 616 MEUR of total commitments for its long-term single asset investment vehicle for Medix Biochemica.

MX3 DIAGNOSTICS LAUNCHES HEAT STRESS MANAGEMENT TOOLKIT

MX3's new Heat Stress Management Toolkit helps organizations combat heat-related stress with real-time monitoring and risk mitigation.

eClinical Solutions Announces Growth Investment by GI Partners to Further Its Mission of Helping Bring Treatments to Patients Faster

eClinical Solutions LLC, a global provider of digital clinical software and services, today announced that GI Partners, a private investment firm, has made a majority investment in the company to advance the future of digital trials via continued enhancements to its leading AI-powered data products and biometrics services.

PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the launch of MET Predict† on the AISightⓇ† Image management system (IMS). MET Predict is an AI-powered algorithm designed to help pathologists identify non-small cell lung cancer (NSCLC) tumors that may be more likely to have MET exon 14 skipping (METex14) or MET amplification, directly from an H&E whole slide image.

Verisense Health Introduces an iOS App for its Smart Watch

The Verisense Smart Watch, Which Collects Digital Health Data During Clinical Trials, is Now Compatible with Both Apple and Android Smartphones.

Fimlab Is Adopting Proscia’s Software To Realize The Promise Of AI-Enabled Pathology

Fimlab Laboratories, Finland’s largest provider of laboratory services, research, and training, is taking the next step on its digital pathology journey with Proscia®, a global leader in AI-enabled pathology solutions for precision medicine. The company will use Proscia’s software platform to help its pathologists generate more precise results with artificial intelligence (AI).

Baylor Genetics’ Presentations at the National Society for Genetic Counselors’ 2024 Annual Meeting Highlight How Genetic Testing Can End the Diagnostic Odyssey

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will participate in the “This or That? Debating the Role of Panels, Exomes, and Genomes in the Diagnostic Odyssey” Educational Breakout Session (EBS), and will present two posters at the upcoming National Society for Genetic Counselors’ (NSGC) 2024 Annual Meeting taking place September 17 – 21, 2024 at the New Orleans Ernest N. Morial Convention Center in New Orleans, LA. Baylor Genetics will also be exhibiting in booth 427.

Proscia And Smart Reporting Partner To Help Pathologists Guide Clinical Care Teams

Proscia and Smart Reporting have partnered to help pathologists inform treatment decisions.

Medical University of Graz Selects the HALO AP® Digital Pathology Platform to Deliver Comprehensive Diagnostics

Indica Labs has announced the Diagnostics & Research Institute for Pathology at the Medical University of Graz has selected the HALO AP® digital pathology platform from Indica Labs to deliver primary diagnostics, alongside Aperio GT 450 scanners from Leica Biosystems.

Indica Labs and Paige Forge Strategic Partnership to Expand Integrated AI for Anatomic Pathology Labs

Indica Labs and Paige have formed a non-exclusive partnership aimed at integrating Paige’s Diagnostic AI models into Indica’s robust Anatomic Pathology workflow management software, HALO AP®.

Baylor Genetics to Offer Webinar, “RNAseq: Enhancing Rare Disease Insights from WES & WGS”

Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, will host a webinar, “RNAseq: Enhancing Rare Disease Insights from WES & WGS,” that will explore the company’s new RNAseq offering and its impact on advancing rare disease insights from Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS).

PathAI's AISightⓇ Dx Image Management System is CE Marked for Primary Diagnosis

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that its AISightⓇ Dx Image Management System (IMS) is In Vitro Diagnostic Regulation (IVDR) certified for use in primary diagnosis. The CE mark paves the way for the company's expansion in the European diagnostic pathology market, enhancing pathologists' interpretations and driving efficiencies and quality improvements within anatomic pathology laboratories.

Gene by Gene Expands NGS Capabilities with New Tech Investment

Association for Molecular Pathology Files Lawsuit Against FDA to Challenge Final Rule on Regulation for Laboratory Developed Testing Procedures

The Association for Molecular Pathology and world-renowned pathologist Michael Laposata, MD, PhD, today announced the filing of a lawsuit challenging the recent U.S. Food and Drug Administration (FDA) Rule that regulates laboratory developed test (LDT) procedures.

International Consortium to Revolutionize Viral Vector Manufacturing

Abselion has announced the collaboration of leading biotechnology companies and research organizations in UK and Canada to develop next-generation cell platform for viral vector production.

Biopharma PEG Expands Multi-Arm PEG Product Line for Medical and Biopharma Applications

Phastar named in 2024 Environment 100 List

Phastar named in 2024 Environment 100 List Phastar continues to lead the CRO industry in corporate responsibility as CEO Graham Clark is named in list of trailblazers, innovators and visionaries.